OCT a useful glaucoma diagnostic

Article

Optical Coherence Tomography (OCT) provides a convenient and quick method of assessing the configuration of the anterior chamber.

Optical Coherence Tomography (OCT) provides a convenient and quick method of assessing the configuration of the anterior chamber, according to the results of a study published in the June issue of Acta Ophthalmologica Scandinavia.

Maya Kalev-Landoy and colleagues from The Western Eye Hospital, London and the Institute of Ophthalmology, University College London, London, UK evaluated the use of OCT in patients with different angle configurations in a prospective observational study of 26 eyes of 26 patients.

A total of 16 patients had abnormal angle configurations, including narrow or closed angles and plateau irides. In each case, OCT provided high-resolution information and the anterior chamber angle could be clearly visualized in patients with narrow or closed angles.

The results suggest that OCT could prove helpful during routine clinical assessment and treatment of patients with glaucoma, particularly when gonioscopy is not possible.

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.